Human pd-l1-binding immunoglobulins

The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human Programmed Death Ligand-1 (huPDL1) and to applications of such polypeptides such as for use as a medicament or for use as diagnostic agent, for example as an immunotracer.

Patent Publication Number: EP3758742

Year filing: 2021

Year approval: 2022

Validated for IOF-key: Yes

Attributed to: Universitaire Associatie Brussel